The clinical significance of mesenchyme forkhead 1 (FoxC2) in gastric carcinoma

Histopathology

Volumn 62, Issue 7, 2013, Pages 1038-1048

  Zhu, Jin Liang ^a   Song, Yong Xi ^a   Wang, Zhen Ning ^a   Gao, Peng ^a   Wang, Mei Xian ^a   Dong, Yu Lan ^a   Xing, Cheng Zhong ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; FoxC2; Gastric carcinoma; P120 catenin; Prognosis

Indexed keywords

P120CTN PROTEIN; PROTEIN; TRANSCRIPTION FACTOR FOXC2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR DIFFERENTIATION; TUMOR INVASION;

ADENOCARCINOMA; CATENINS; CHINA; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877899742     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12132     Document Type: Article

References (40)

1. Krejs GJ. Gastric cancer: epidemiology and risk factors. Dig. Dis. 2010; 28; 600-603.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int. J. Cancer 2010; 127; 2893-2917.
3. Murray G, Duncan M, Arbuckle E, Melvin W, Fothergill J. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 1998; 43; 791-797.
4. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002; 2; 442-454.
5. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139; 871-890.
6. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 2009; 119; 1438-1449.
7. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA. A switch from e-cadherin to n-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin. Cancer Res. 2007; 13; 7003-7011.
8. Iwatsuki M, Mimori K, Yokobori T et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010; 101; 293-299.
9. Mani SA, Yang J, Brooks M et al. Mesenchyme forkhead 1 (foxc2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl Acad. Sci. USA 2007; 104; 10069-10074.
10. Yu YH, Chen HA, Chen PS et al. Mir-520h-mediated foxc2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 2013; 32; 431-443.
11. Nishida N, Mimori K, Yokobori T et al. Foxc2 is a novel prognostic factor in human esophageal squamous cell carcinoma. Ann. Surg. Oncol. 2011; 18; 535-542.
12. Jiang W, Pang XG, Wang Q, Shen YX, Chen XK, Xi JJ. Prognostic role of twist, slug, and foxc2 expression in stage I non-small-cell lung cancer after curative resection. Clin. Lung Cancer 2012; 13; 280-287.
13. Peinado H, Olmeda D, Cano A. Snail, zeb and bhlh factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 2007; 7; 415-428.
14. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008; 14; 818-829.
15. Uchikado Y, Okumura H, Ishigami S et al. Increased slug and decreased e-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer 2011; 14; 41-49.
16. Jouppila-Matto A, Narkio-Makela M, Soini Y et al. Twist and snail expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression. BMC Cancer 2011; 11; 350.
17. Kyo S, Sakaguchi J, Ohno S et al. High twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum. Pathol. 2006; 37; 431-438.
18. Davis MA, Ireton RC, Reynolds AB. A core function for p120-catenin in cadherin turnover. J. Cell Biol. 2003; 163; 525-534.
19. Reynolds AB, Carnahan RH. Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer. Semin. Cell Dev. Biol. 2004; 15; 657-663.
20. Bellovin DI, Bates RC, Muzikansky A, Rimm DL, Mercurio AM. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res. 2005; 65; 10938-10945.
21. Jawhari AU, Noda M, Pignatelli M, Farthing M. Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma. J. Pathol. 1999; 189; 180-185.
22. Liu Y, Li QC, Miao Y et al. Ablation of p120-catenin enhances invasion and metastasis of human lung cancer cells. Cancer Sci. 2009; 100; 441-448.
23. Mortazavi F, An J, Dubinett S, Rettig M. P120-catenin is transcriptionally downregulated by foxc2 in non-small cell lung cancer cells. Mol. Cancer Res. 2010; 8; 762-774.
24. Hamilton SR, Aaltonen LA eds. Pathology and genetics of tumours of the digestive system. World Health Organization classification of tumours, vol. 2. Lyon, France: IARC Press, 2000.
25. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995; 55; 237-241.
26. Resnick MB, Gavilanez M, Newton E et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum. Pathol. 2005; 36; 886-892.
27. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992; 52; 6735-6740.
28. Natalwala A, Spychal R, Tselepis C. Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J. Gastroenterol. 2008; 14; 3792-3797.
29. Alves CC, Rosivatz E, Schott C et al. Slug is overexpressed in gastric carcinomas and may act synergistically with sip1 and snail in the down-regulation of e-cadherin. J. Pathol. 2007; 211; 507-515.
30. Kim MA, Lee HS, Lee HE, Kim JH, Yang HK, Kim WH. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology 2009; 54; 442-451.
31. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R. Differential expression of the epithelial-mesenchymal transition regulators snail, sip1, and twist in gastric cancer. Am. J. Pathol. 2002; 161; 1881-1891.
32. Watanabe T, Kobunai T, Yamamoto Y et al. Gene expression of mesenchyme forkhead 1 (foxc2) significantly correlates with the degree of lymph node metastasis in colorectal cancer. Int. Surg. 2011; 96; 207-216.
33. Sano H, Leboeuf JP, Novitskiy SV et al. The foxc2 transcription factor regulates tumor angiogenesis. Biochem. Biophys. Res. Commun. 2010; 392; 201-206.
34. Hayashi H, Kume T. Forkhead transcription factors regulate expression of the chemokine receptor cxcr4 in endothelial cells and cxcl12-induced cell migration. Biochem. Biophys. Res. Commun. 2008; 367; 584-589.
35. Hayashi H, Sano H, Seo S, Kume T. The foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. J. Biol. Chem. 2008; 283; 23791-23800.
36. Hayashi H, Kume T. Foxc2 transcription factor as a regulator of angiogenesis via induction of integrin beta3 expression. Cell. Adh. Migr. 2009; 3; 24-26.
37. Reynolds AB, Herbert L, Cleveland JL, Berg ST, Gaut JR. P120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo. Oncogene 1992; 7; 2439-2445.
38. Yanagisawa M, Anastasiadis PZ. P120 catenin is essential for mesenchymal cadherin-mediated regulation of cell motility and invasiveness. J. Cell Biol. 2006; 174; 1087-1096.
39. Wijnhoven BP, Pignatelli M, Dinjens WN, Tilanus HW. Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction. J. Surg. Oncol. 2005; 92; 116-123.
40. Chung Y, Lam AK, Luk JM et al. Altered e-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma. Ann. Surg. Oncol. 2007; 14; 3260-3267.